Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT

NCT04560218 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

OTHER_GOV

Sponsor class

Conditions

To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women

Interventions

DRUG: sublingual Misoprostol
DRUG: Intrauterine Misoprostol

Sponsor

Department of Medical Services Ministry of Public Health of Thailand